Onterris Q2 2026 presentation: guidance cut on weak emergency work

Onterris (formerly Montrose Environmental Group) reported Q2 2026 revenue of $186.7M, down 20% ($47.9M) year over year, with adjusted EBITDA margin improving to 17.1% from 16.9% but shares falling 18% after-hours to $18.56. The company cut full-year revenue guidance to $740M–$790M from $840M–$900M (and adjusted EBITDA to $117M–$120M from $125M–$130M), citing weaker emergency response activity and ~$15M–$25M impacts from temporary regulatory waivers. Operating cash flow for 1H 2026 was -$5.5M (vs +$27.4M a year earlier), though management expects $70M–$80M of operating cash flow in 2H to fund buybacks (1.6M shares for ~$30M) and maintain leverage around 2.5x by year-end.

Analysis

This is more a visibility problem than a true competitive loss, which matters for how the stock should trade. The revenue reset came from a low-event-cycle business line and temporary regulatory timing, but the market is usually harsher on names where headline growth can swing 15-25% without much warning; that keeps the multiple capped even if EBITDA margin improves. The key question is not whether margins can hold — they likely can — but whether investors are willing to pay for a business whose top line is hostage to lumpy demand and working-capital noise.

Second-order, the softer pass-through mix is a hidden negative because it can make reported revenue look worse without proportionally lowering EBITDA, which invites “quality of growth” discounting from generalists. On the other hand, if the company can convert the second half into the promised cash flow, leverage moving toward 2.5x gives management optionality for buybacks and small deals, which could support the floor. That creates a mismatch: near-term sentiment stays weak, but the balance sheet risk is not the central issue unless operating cash flow misses again.

Contrarian take: the market may be over-anchoring on the guidance cut as if it were secular demand destruction. If emergency response normalizes even partially over the next 1-3 quarters, the earnings revision cycle could reverse quickly because the company has already taken out cost. The real falsifier is another quarter of depressed event activity plus weak cash conversion; if that happens, the “temporary” story breaks and the stock deserves a lower multiple for 6-18 months.

Key Decisions for Investors

• Short-term: consider selling rallies in MEG/ONT into any post-earnings rebound above the gap-down level; the setup favors a slower multiple re-rating until emergency response normalizes.
• Pair trade: long CLH / short MEG as a relative quality spread — cleaner earnings visibility and less event-cycle dependence versus a name still proving that margin expansion can offset revenue volatility.
• Options: buy 1-3 month puts only if the stock fails to reclaim pre-earnings support after the first trading session; otherwise the setup is better expressed via equity short, not expensive premium.
• Watch item: if 3Q revenue lands at the high end and operating cash flow inflects toward the guided second-half range, cover shorts quickly — that would be the first credible catalyst for a de-risking rally.
• Longer horizon: if leverage trends toward 2.5x and the strategic review becomes concrete, revisit for a special-situations long; until then, treat buyback/bolt-on optionality as support, not a catalyst.